» Articles » PMID: 8556063

Increase in Serum Interleukin-6, Plasma ACTH and Serum Cortisol Levels After Systemic Interferon-alpha Administration

Overview
Journal Endocr J
Specialty Endocrinology
Date 1995 Aug 1
PMID 8556063
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic administration of human interferon-alpha stimulates the pituitary-adrenal axis in men, but the exact mechanism still remains to be established. The present study was undertaken to examine the hypothesis that interferon-alpha may alter the circulating concentrations of the cytokines which involve the activation of the pituitary-adrenal axis. Eleven patients with chronically active hepatitis C were treated with human lymphoblastoid interferon-alpha (IFN: 6 x 10(6) IU/day) and changes in plasma adrenocorticotropin (ACTH), serum cortisol and cytokine concentrations were observed on both the first and second days of the treatment. Subcutaneous administration of IFN significantly increased plasma ACTH and serum cortisol concentrations by 3 h after the injection. Serum interleukin-6 (IL-6) increased with the increase in circulating ACTH and cortisol. There was a significant correlation between serum cortisol and IL-6 concentrations at 3 h. In contrast, an increase in serum interleukin-1 beta was only observed in one case. On the second day of IFN treatment, simultaneous administration of 25 mg diclofenac sodium eliminated the IFN effects on circulating ACTH, cortisol and IL-6 concentrations. The present studies demonstrated that circulating IL-6 increases after systemic IFN administration, resulting in activation of the pituitary-adrenal axis.

Citing Articles

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Felger J, Lotrich F Neuroscience. 2013; 246:199-229.

PMID: 23644052 PMC: 3741070. DOI: 10.1016/j.neuroscience.2013.04.060.


Gene expression biomarkers of response to citalopram treatment in major depressive disorder.

Mamdani F, Berlim M, Beaulieu M, Labbe A, Merette C, Turecki G Transl Psychiatry. 2012; 1:e13.

PMID: 22832429 PMC: 3309465. DOI: 10.1038/tp.2011.12.


Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy.

Schlaak J, Trippler M, Hoyo-Becerra C, Erim Y, Kis B, Wang B PLoS One. 2012; 7(6):e38668.

PMID: 22701688 PMC: 3368901. DOI: 10.1371/journal.pone.0038668.


Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality.

Prather A, Rabinovitz M, Pollock B, Lotrich F Brain Behav Immun. 2009; 23(8):1109-16.

PMID: 19615438 PMC: 2783448. DOI: 10.1016/j.bbi.2009.07.001.


Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.

Anisman H J Psychiatry Neurosci. 2009; 34(1):4-20.

PMID: 19125209 PMC: 2612083.